Advertisement

Topics

Illumina enters companion Dx development partnership with BMS

07:09 EDT 16 Apr 2018 | SmartBrief

A partnership was reached by Illumina and Bristol-Myers Squibb to create and commercialize companion diagnostics for the phar -More

Original Article: Illumina enters companion Dx development partnership with BMS

NEXT ARTICLE

More From BioPortfolio on "Illumina enters companion Dx development partnership with BMS"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...